Marc Port is a chemical engineer graduated from the Ecole Nationale Supérieure de Chimie de Paris. He completed his PhD by carrying out a new total synthesis of trenbolone acetate. He then joined Guerbet company where he became Director of Drug Discovery. He then became Professor of the Pharmaceutical Chemistry Chair at Cnam in 2014 where he is currently the head of the Molecular Chemistry team. His main areas of research focus on medicinal chemistry and on the design of theranostic agents. His research has led to around 80 international scientific publications and 43 international patents.